Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03515551
Title Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunocore Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | CAN

Facility Status City State Zip Country Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
UPMC - Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology NASH - SCRI Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Sarah Cannon Research Institute UK London W1G 6AD United Kingdom Details
The Christie Hospital Manchester M20 4BX United Kingdom Details
Royal Marsden Hospital Sutton SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field